Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Wound exudate proteins/proteases" is not a single molecular target but rather refers collectively to the **various protein-degrading enzymes present in the fluid produced by wounds**. The most significant among these are **matrix metalloproteinases (MMPs)** and **serine proteases** such as human neutrophil elastase. These enzymes are essential for normal tissue repair—they degrade damaged extracellular matrix components like collagen and gelatin during the early phases of healing, enabling new tissue formation[1][4]. However, when their activity becomes excessive or dysregulated—often seen in chronic or infected wounds—they can degrade newly formed matrix proteins, growth factors, and cell surface receptors. This disrupts the balance between tissue breakdown and regeneration, leading to impaired healing or stalled wounds[1][2][3]. Proteolytic activity within wound exudate comes from both host cells (such as neutrophils) and invading bacteria; bacterial infection can further increase destructive enzyme levels through secretion of their own virulence-associated proteases[3][4]. Monitoring these enzyme activities has diagnostic value—high levels correlate with poor prognosis for healing—and several point-of-care tests have been developed for this purpose. Because "wound exudate proteins/proteases" encompasses a group rather than a single defined molecule/receptor with a unique gene/protein product or standardized abbreviation, it is not considered an individual therapeutic target but rather a class relevant to disease pathology. Therapeutic strategies focus on modulating overall enzymatic activity using topical dressings containing specific inhibitors. This entry is marked as incorrect because it does not refer to one canonical molecular entity but instead describes a heterogeneous mixture of related enzymes found within wound fluids[1][2][4].
Inhibition of excessive enzymatic activity to restore balance between tissue breakdown and repair[1][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wound exudate protease.